Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Peck

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Clinical Pharmacokinetics|December 31, 2015
Combining 'Bottom-Up' and 'Top-Down' Methods to Assess Ethnic Difference in Clearance: Bitopertin as an ExampleSheng Feng, Jun Shi, Neil Parrott, et al.
Clinical Pharmacology and Therapeutics|April 18, 2019
A Framework Proposal to Follow-Up on Preclinical Convulsive Signals of a New Molecular Entity in First-in-Human Studies Using Electroencephalographic MonitoringMarkus Abt, Theo Dinklo, Andreas Rothfuss, et al.
Drug Discovery Today|December 14, 2019
Schrödinger's pipeline and the outsourcing of pharmaceutical innovationPeter McMeekin, Dennis W Lendrem, B Clare Lendrem, et al.
British Journal of Clinical Pharmacology|February 18, 2014
Bayesian adaptive designs in single ascending dose trials in healthy volunteersDavid Guédé, Bruno Reigner, Francois Vandenhende, et al.
Journal of Translational Medicine|June 23, 2012
Clinical trial considerations on male contraception and collection of pregnancy information from female partnersMaria Longauer Banholzer, Heinrich Buergin, Christoph Wandel, et al.
Journal of Clinical Pharmacology|April 14, 2010
The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of RO5068760, an MEK inhibitor, in healthy volunteers: assessment of target suppressionLucy Lee, Huifeng Niu, Petra Goelzer, et al.
Clinical and Translational Medicine|July 27, 2016
Clinical trial considerations on male contraception and collection of pregnancy information from female partner: updateMaria Longauer Banholzer, Christoph Wandel, Paul Barrow, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2015
Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumorsAmita Patnaik, Anthony Tolcher, Murali Beeram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of CH4987655 in healthy volunteers: target suppression using a biomarkerLucy Lee, Huifeng Niu, Ruediger Rueger, et al.
NPJ Digital Medicine|June 23, 2026
Causal inference and digital twins: a roadmap for the future of clinical trialsSilas Ruhrberg Estévez, Richard Peck, Eoin McKinney, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Pharmacokinetics|December 31, 2015
Combining 'Bottom-Up' and 'Top-Down' Methods to Assess Ethnic Difference in Clearance: Bitopertin as an ExampleSheng Feng, Jun Shi, Neil Parrott, et al.
Clinical Pharmacology and Therapeutics|April 18, 2019
A Framework Proposal to Follow-Up on Preclinical Convulsive Signals of a New Molecular Entity in First-in-Human Studies Using Electroencephalographic MonitoringMarkus Abt, Theo Dinklo, Andreas Rothfuss, et al.
Drug Discovery Today|December 14, 2019
Schrödinger's pipeline and the outsourcing of pharmaceutical innovationPeter McMeekin, Dennis W Lendrem, B Clare Lendrem, et al.
British Journal of Clinical Pharmacology|February 18, 2014
Bayesian adaptive designs in single ascending dose trials in healthy volunteersDavid Guédé, Bruno Reigner, Francois Vandenhende, et al.
Journal of Translational Medicine|June 23, 2012
Clinical trial considerations on male contraception and collection of pregnancy information from female partnersMaria Longauer Banholzer, Heinrich Buergin, Christoph Wandel, et al.
Journal of Clinical Pharmacology|April 14, 2010
The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of RO5068760, an MEK inhibitor, in healthy volunteers: assessment of target suppressionLucy Lee, Huifeng Niu, Petra Goelzer, et al.
Clinical and Translational Medicine|July 27, 2016
Clinical trial considerations on male contraception and collection of pregnancy information from female partner: updateMaria Longauer Banholzer, Christoph Wandel, Paul Barrow, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2015
Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumorsAmita Patnaik, Anthony Tolcher, Murali Beeram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
The safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of CH4987655 in healthy volunteers: target suppression using a biomarkerLucy Lee, Huifeng Niu, Ruediger Rueger, et al.
NPJ Digital Medicine|June 23, 2026
Causal inference and digital twins: a roadmap for the future of clinical trialsSilas Ruhrberg Estévez, Richard Peck, Eoin McKinney, et al.
Pageof 3